4.19.2023 Board Book

OMA Board of Trustees (BOT) Meeting Minutes January 9th, 2023 4:00pm – 6:00pm MST Held Virtually: https://obesitymedicine org.zoom.us/j/88530631804?pwd=VWV4aFNuSnFGdlFJOFNtZWNxQitPZz09 Call to Order: The BOT meeting was called to order at 4:03 pm (MST) by Presiding Officer, Dr. Angela Fitch Roll Call: Dr. Marisa Censani Attendees: Dr. Ethan Lazarus, Dr. Lydia Alexander, Dr. Harold Bays, Dr. Anthony Auriemma, Ms. Sandra Christensen, Dr. Suzanne Cuda, Dr. Carolynn Francavilla Brown, Dr. Michelle Freshwater, Dr. Bharti Shetye, Dr. Craig Primack, Mrs. Teresa Fraker (OMA Executive Director), and Ms. Lydia Haile (OMA Operations Specialist). - At the time of roll call, Dr. Sylvia Gonsahn-Bollie was not present however she arrived within a few minutes after roll call was completed and she was present for the entire meeting. Conflict of Interest Disclosures Dr. Bays corrected his disclosures to reflect that he is on the board of directors for the American Society for Preventative Cardiology not the National Lipid Association as currently stated in the book. Furthermore, Dr. Bays shared that was contacted by the National Lipid Association for an opportunity to produce a joint statement on obesity and cardiovascular disease that he hopes to work on in collaboration with the American Society for Preventative Cardiology. Dr. Fitch updated her disclosures to reflect her involvement with Eli Lilly, Novo Nordisk, Vivus Advisory Board, Sidekick Health, and CinRX. Dr. Censani updated her disclosures to include that she is a member of The Endocrine Society and the Pediatric Endocrine Society. Dr. Censani also shared she recently completed a three-year term as the Pediatric Endocrine Society co-chair. Ms. Christensen updated her disclosures to include that she is a trustee for the Washington Obesity Society as well as a member and a speaker for the American Association of Nurse Practitioners (AANP). Dr. Gonsahn-Bollie updated her disclosures to include that she is a Shaklee ambassador and has done consulting for Novo Nordisk. She has also been recruited to be a medical director for Phsysicans.com The above disclosure additions and corrections were updated accordingly.

Approval of the Agenda

Page | 1